|
|
|
Volumn 26, Issue 2, 1999, Pages 234-243
|
|
Novel molecular targets for prostate cancer therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ARYLBUTYRIC ACID DERIVATIVE;
ESTRAMUSTINE;
ETOPOSIDE;
FLAVOPIRIDOL;
LIAROZOLE;
MATRIX METALLOPROTEINASE;
PACLITAXEL;
PECTIN;
PHENYLACETIC ACID;
QUINOLINE DERIVATIVE;
SURAMIN;
THALIDOMIDE;
VINBLASTINE;
ANGIOGENESIS;
CELL CYCLE;
CELL STRUCTURE;
CLINICAL TRIAL;
DRUG RESEARCH;
DRUG SCREENING;
HUMAN;
MALE;
METASTASIS;
PRIORITY JOURNAL;
PROSTATE CANCER;
REVIEW;
ANGIOGENESIS INHIBITORS;
ANTINEOPLASTIC AGENTS;
CELL CYCLE;
CELL DIFFERENTIATION;
DNA, NEOPLASM;
EXTRACELLULAR MATRIX;
GROWTH SUBSTANCES;
HUMANS;
MALE;
MOLECULAR BIOLOGY;
NEOPLASM METASTASIS;
PROSTATIC NEOPLASMS;
|
|
EID: 0032961211
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (10)
|
|
References (97)
|
